Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Review

Published on 23 Jan 2023

Bibliometric analysis and evidence of clinical efficacy and safety of digital pills

in Drugs Outcomes Research and Policies

Olena Litvinova
Elisabeth Klager
Andy Wai Kan Yeung
Nikolay T. Tzvetkov
Oliver Kimberger
Maria Kletecka-Pulker
Harald Willschke
Atanas G. Atanasov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1023250

6,324 views
4 citations

Systematic Review

Published on 20 Jan 2023

A systematic review and Bayesian meta-analysis of the antibiotic treatment courses in AECOPD

in Drugs Outcomes Research and Policies

Haichuan Yu
Ting Lei
Xiaojie Su
Lu Zhang
Zhouzhou Feng
Xinlong Chen
Jian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1024807

3,278 views
6 citations

Opinion

Published on 20 Jan 2023

Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities

in Drugs Outcomes Research and Policies

Qingqing Yin
Dandan Feng
Yong Zhao
Xiaojuan Zhu
Yan Dong
Jianchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106144

1,463 views
1 citation

Systematic Review

Published on 20 Jan 2023

Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review

in Drugs Outcomes Research and Policies

Nina Jahnich
Peter D. Arkwright

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1046306

3,022 views
9 citations

Original Research

Published on 16 Jan 2023

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia

in Drugs Outcomes Research and Policies

Monika Lassanova
Stefan Lassan
Silvia Liskova
Tomas Tesar
Monika Cicova

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097890

3,707 views
3 citations

Original Research

Published on 13 Jan 2023

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

in Drugs Outcomes Research and Policies

Caitriona Cahir
Carmel Curran
Caroline Walsh
Anne Hickey
Ross Brannigan
Ciara Kirke
David J. Williams
Kathleen Bennett

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1029067

8,441 views
24 citations

Perspective

Published on 12 Jan 2023

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

in Drugs Outcomes Research and Policies

Kendra K. Radtke
Atul J. Butte

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054688

2,284 views
1 citation

Original Research

Published on 12 Jan 2023

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

in Drugs Outcomes Research and Policies

Wenjiao Tang
Jinrong Yang
Yan Li
Li Zhang
He Li
Jie Wang
Yi Liao
Chunlan Zhang
Ying Qu
Yuhuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.979111

3,970 views
5 citations

Correction

Published on 11 Jan 2023

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

in Drugs Outcomes Research and Policies

Geeta S. Bhagwat
Rajani B. Athawale
Rajeev P. Gude
Shadab Md
Nabil A. Alhakamy
Usama A. Fahmy
Prashant Kesharwani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1123542

1,231 views

Clinical Trial

Published on 10 Jan 2023

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

in Drugs Outcomes Research and Policies

Muhammed Yunus Bektay
Mesut Sancar
Fatmanur Okyaltirik
Bulent Durdu
Fikret Vehbi Izzettin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049289

2,920 views
7 citations

Systematic Review

Published on 10 Jan 2023

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xiaofeng Luo
Min Hou
Shuangshuang He
Xue Yang
Pan Zhang
Yingxin Zhao
Haiyan Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1021584

9,021 views
10 citations

Original Research

Published on 10 Jan 2023

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

in Drugs Outcomes Research and Policies

Jieun Kang
Man Pyo Chung
Moo Suk Park
In Jae Oh
Heung Bum Lee
Young Whan Kim
Jong Sun Park
Soo Taek Uh
Yun Seong Kim
Yangjin Jegal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025947

3,741 views
7 citations

Original Research

Published on 09 Jan 2023

Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis

in Drugs Outcomes Research and Policies

Sai Huang
Bo Yang
Yaojun Peng
Qinrui Xing
Lili Wang
Jing Wang
Xuan Zhou
Yuan Yao
Li Chen
Cong Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059285

5,162 views
1 citation

Editorial

Published on 09 Jan 2023

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

in Drugs Outcomes Research and Policies

Mansour Adam Mahmoud
Johanna C. Meyer
Ahmed Awaisu
Joseph Fadare
Ahmed Ibrahim Fathelrahman
Fahad Saleem
Hisham Aljadhey
Brian Godman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1124371

1,894 views

Review

Published on 09 Jan 2023

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives

in Drugs Outcomes Research and Policies

Zherui Liu
Yun Zhu
Huan Xie
Zhengsheng Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1077468

15,644 views
37 citations

Original Research

Published on 04 Jan 2023

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD

in Drugs Outcomes Research and Policies

P. Barnestein-Fonseca
VM. Cotta-Luque
VP. Aguiar-Leiva
J. Leiva-Fernández
Francisco Martos-Crespo
F. Leiva-Fernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.989362

3,652 views
7 citations